Canada markets closed

Satsuma Pharmaceuticals, Inc. (STSA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.8500-0.0800 (-1.62%)
At close: 4:00PM EDT

4.8500 0.00 (0.00%)
After hours: 4:00PM EDT

Currency in USD

Valuation Measures

Market Cap (intraday) 5152.92M
Enterprise Value 325.16M
Trailing P/E N/A
Forward P/E 1-2.59
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.69
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-0.54

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-78.01%
S&P500 52-Week Change 343.61%
52 Week High 336.1050
52 Week Low 33.5000
50-Day Moving Average 35.3089
200-Day Moving Average 35.3223

Share Statistics

Avg Vol (3 month) 3242.22k
Avg Vol (10 day) 3132.18k
Shares Outstanding 531.53M
Implied Shares Outstanding 6N/A
Float 15.41M
% Held by Insiders 19.90%
% Held by Institutions 154.78%
Shares Short (Apr. 29, 2021) 4868.7k
Short Ratio (Apr. 29, 2021) 46.67
Short % of Float (Apr. 29, 2021) 43.86%
Short % of Shares Outstanding (Apr. 29, 2021) 42.76%
Shares Short (prior month Mar. 30, 2021) 4758.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.60%
Return on Equity (ttm)-38.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -46.34M
Net Income Avi to Common (ttm)-46.25M
Diluted EPS (ttm)-11.2010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)133.12M
Total Cash Per Share (mrq)4.22
Total Debt (mrq)2.84M
Total Debt/Equity (mrq)2.05
Current Ratio (mrq)25.50
Book Value Per Share (mrq)7.03

Cash Flow Statement

Operating Cash Flow (ttm)-37.8M
Levered Free Cash Flow (ttm)-27.54M